Industries > Pharma > Global Vaccine Contract Manufacturing Market Report 2019-2029

Global Vaccine Contract Manufacturing Market Report 2019-2029

Paediatric Vaccines, Adult Vaccines, Influenza Vaccines, Therapeutic Vaccines, Downstream Processing, Fill & Finish Operations, Analytical & QC Studies, Packaging, Upstream Processing, Mammalian Expression Systems, Bacterial Expression Systems, Yeast Expression Systems, Baculovirus/Insect Expression Systems, Other Upstream Processing

PUBLISHED: 02 April 2019
PAGES: 217
PRODUCT CODE: PHA0383

Clear
WOOCS 2.2.1
DOWNLOAD SAMPLE

The global vaccine contract manufacturing market was worth $1.9bn in 2018 and is expected to grow at a CAGR of 9.3% from 2019-2023. In 2018, the paediatric vaccines segment held 48% of the global vaccine contract manufacturing market.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 217-page report you will receive 80 tables and 57 figures– all unavailable elsewhere.

The 217-page report provides clear detailed insight into the global vaccine contract manufacturing market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand new report today you stay better informed and ready to act.

Report Scope

• Revenue and growth forecasts from 2019 to 2029 for the global vaccine market

• Revenue and growth forecasts from 2019 to 2029 for the global vaccine contract manufacturing market

• Revenue and growth forecasts from 2019 to 2029 for the global vaccine contract manufacturing market by type:
• Paediatric Vaccines
• Adult Vaccines
• Influenza Vaccines
• Therapeutic Vaccines

• Revenue and growth forecasts from 2019 to 2029 for the global vaccine contract manufacturing market by workflow:
• Downstream Processing: the revenues are further broken down into Fill & Finish Operations, Analytical & QC Studies, Packaging
• Upstream Processing: the revenues are further broken down into Mammalian Expression Systems, Bacterial Expression Systems, Yeast Expression Systems, Baculovirus/Insect Expression Systems, Other Upstream Processing

• Revenue and growth forecasts from 2019 to 2029 for the leading regional and national markets:
• North America: the revenues are further broken down into the US and Canada
• Europe: the revenues are further broken down into the UK, Germany, France, Italy and Spain
• Asia-Pacific: the revenues are further broken down into China, Japan and India
• Rest of the World: the revenues are further broken down into Brazil, Mexico, Russia and South Africa

Global Vaccine Contract Manufacturing Market Report 2019-2029

The regional markets are further broken down by type and workflow.

• Discussion and profiles of the leading players in the vaccine contract manufacturing market:
• AbbVie
• Baxter BioPharma Solutions
• Boehringer Ingelheim
• Catalent
• Charles River Laboratories
• Evonik Degusa
• IDT Biologika
• Lonza
• Meridian Life Science
• Nipro Corporation
• Pfizer CentreOne
• Sigma Aldrich Fine Chemicals
• SynCo Bio Partners
• Vetter Pharmaceutical

• A SWOT analysis discussing the industry trends, strengths, weaknesses, opportunities and threats.

• Discussion on vaccine manufacturing technologies covering new substrates for vaccine production, next-generation expression systems and vectors, equipment trends, pre-filled syringes and vaccines, lyophilization and vaccine manufacturing, cell-based techniques.

• Key Questions Answered by this Report:
• How is the vaccine contract manufacturing market evolving?
• What is driving and restraining the vaccine contract manufacturing market?
• What are the market shares of the leading segments of the vaccine contract manufacturing market in 2018?
• What is the value of the leading sectors in important regions of the world?
• What will be the main driver of the overall market from 2019 to 2029?
• How will political and regulatory factors influence the regional markets and submarkets?
• Will leading national vaccine contract manufacturing markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
• How will the market shares of the leading national markets change by 2029 and which country will lead the market in 2029?
• How will the industry evolve during the period between 2019 and 2029?

Visiongain’s study is intended for anyone requiring commercial analyses for the global vaccine contract manufacturing market. You find data, trends and predictions.

Buy our report today Global Vaccine Contract Manufacturing Market Report 2019-2029: Paediatric Vaccines, Adult Vaccines, Influenza Vaccines, Therapeutic Vaccines, Downstream Processing, Fill & Finish Operations, Analytical & QC Studies, Packaging, Upstream Processing, Mammalian Expression Systems, Bacterial Expression Systems, Yeast Expression Systems, Baculovirus/Insect Expression Systems, Other Upstream Processing.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Global Vaccine Contract Manufacturing Market Report 2019-2029


Download sample pages

Complete the form below to download your free sample pages for Global Vaccine Contract Manufacturing Market Report 2019-2029


Latest Pharma news

“Global Influenza Vaccines Market Set to Grow to $4.9bn by 2024” says new Visiongain report

The global vaccines market is one that is driven by innovation. This is vital for maintaining the rich pipeline of vaccines seen in the human vaccines market.

05 July 2019

READ

“Pharmaceutical Wholesale & Distribution Organizations 2019 is estimated to reach $1.4bn in 2024” says Visiongain report

Opportunities in the market stem from the increasing use of specialist and generic drugs, which have higher profit margins; global expansion into the emerging markets; vertical integration of wholesalers; and the increasing use of pharmaceuticals.

28 June 2019

READ

“Global Vaccines Sales market set to grow to $75bn by 2024” says new Visiongain report

Progress in R&D in the therapeutic vaccine field will yield revolutionary results and answer unmet medical needs. This will also lead to more innovative approaches to vaccine development.

25 June 2019

READ

“Global Inflammatory Bowel Diseases (IBD) Drug Market is estimated to reach $8.6bn by 2024” says new Visiongain report

Revenue growth will be driven by rising incidence and prevalence owing to modern lifestyles and improved awareness and diagnosis.

21 June 2019

READ

Categories

Category